Osisko Gold Royalties Ltd (the "Company" or "Osisko") (OR: TSX & NYSE) is pleased to provide an update on its fourth quarter 2024 preliminary deliveries, revenues ...
Arbital Health, a healthcare technology and actuarial leader that centralizes, measures, and adjudicates value-based care contracts at scale, is excited to announce the completion of a transaction ...
Effective January 2, 2025, Pasinex granted an aggregate of 2,500,000 stock options, to directors, officers, and key employees. The stock options vest 100% immediately, are exercisable at $0.04 per ...
For the full year 2024, preliminary revenues from royalties and streams reached a record $262.2 million (US$191.2 million) and preliminary cost of sales (excluding depletion) are estimated at $9.3 ...